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Abstract 
Multipassage experiments are performed by subcutaneous implantation in lab animals (usually mice) 
of a small number of cells from selected human lines. Tumor cells are then passaged from one mouse 
to another by harvesting them from a growing tumor and implanting them into other healthy animals. 
This procedure may be extremely useful to investigate the various mechanisms involved in the long 
term evolution of tumoral growth. It has been observed by several researchers that, contrary to what 
happens in in vitro experiments, there is a significant growth acceleration at each new passage. This 
result is explained by a new method of analysis, based on the Phenomenological Universalities 
approach. It is found that, by means of a simple rescaling of time, it is possible to collapse all the 
growth curves, corresponding to the successive passages, into a single curve, belonging to the 
Universality Class U2. Possible applications are proposed and the need of further experimental 
evidence is discussed. 
 
 
 
 
 
Introduction 
The fitting of any given set of experimental data may be just an exercise to find, for practical purposes, 
a convenient analytical curve to represent the data or, at a much deeper level, it may aim to provide 
a model. In the latter case one should restrict one's attention to the raw data and analyse them 
independently of the field of application, in order to extract from them unbiasedly every bit of 
meaningful information. This tough requirement is well described by the old adage “If you torture 
well enough your data, they'll confess”, with the double-entendre that they might “confess” what you 
expect or would like to find, rather than the underlying reality. A totally unbiased procedure to compel 
the data to “confess the truth” may be found in the Phenomenological Universalities (PUN) approach, 
recently proposed by P.P. Delsanto and collaborators [1]–[4], which is briefly described in the Text 
S1. 
Tumor growth data represent perhaps one of the most critical instances of such a predicament. In fact, 
due to the multifaceted complexity of tumor growth mechanisms and their interactions with the host 
tissue, it is important to try to learn as much as possible from the data about avascular and vascular 
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growth, metastasis, invasion, etc. Since clinical data are usually restricted to very few points in time, 
one tries to gain additional information from models, such as Multicellular Tumor Spheroids (MTS) 
[5]–[8], or from ex vivo experiments of transplants in lab animals, such as mice [9]–[11]. Although 
MTS experiments boast some inherent advantages, in the present contribution we are mostly 
concerned with the latter, since they are likely to be a better approximation to in vivo tumoral growth. 
The amount of information which can be retrieved from a given dataset is obviously related to the 
number of experimental “points”, just as in a system of equations in order to solve for M unknowns 
it is necessary that . In fact, in order to reduce the effect of experimental errors, it is usually 
desirable that . However, if new datapoints are added too close to the old ones, little 
information is gained, although the overall statistical accuracy may improve. For this reason multi-
passage experiments (MPE) are performed, as a tool to study the long-term evolution of grafted tumor 
lines: see Figure 1. 
 
 
 
Figure 1. A cartoonist's view of multi-passage experiments. 
In MPE experiments, tumors grow following the subcutaneous implantation on the back of a lab animal (usually mice) 
of ~106 tumor cells (from cell cultures or from surgical resection). Tumor cells are then passaged from one mouse to 
another by harvesting them from a growing tumor and implanting a given number of them into another healthy animal. 
Once the tumor has grown above a certain volume it can be harvested again. This passage of tumor cells is repeated for 
multiple rounds (McCredie et al. [10] report the case of a spontaneous mammary tumor in a C3H mouse, from which the 
first syngenic transplant was done in 1946 and which has been serially transplanted in the C3H/HeJ strain, reaching in 
1971 the 900th generation!). The idea of taking a very small fraction of a spontaneous tumor mass and repeateadly 
transplanting it in a new host seems to reproduce the ideal situation of unlimited resources, and therefore should give us 
some insight about unrestricted tumor growth. 
 
Methods 
It is generally assumed that tumors originate from a “seed” and grow by cell duplication, therefore 
following in the first phase an exponential growth law. As long as no mechanical nor nutritional 
restrictions apply, they go on replicating with a constant duplication time. After a while, however, 
host and other constraints force the development of a necrotic core, and growth slows down towards 
some asymptotic level of saturation. This behaviour is well described by the well known Gompertz 
law [12], which has been heuristically used for more than a century in biology and other disciplines. 
Most aggressive tumors overcome nutrients deprivation by means of angiogenesis, and the neo-
vascular network partly supports growth, as discussed by C Guiot et al. [13], following the model of 
G.B. West and collaborators [14]–[17]. The mechanical pressure induced by the host tissue can be 
circumvented by tumor invasion [18] and/or metastatic diffusion [19]. 
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The progress of growth in the three phases is illustrated in Figure 2, for the case of Multicellular 
Tumor Spheroids [20]. The three phases are also schematically represented in Figure 3, where, 
however, the third phase refers to in vivo tumors. The three phases correspond, for the case of tumor 
growth, to the three PUN classes U0, U1 and U2, which are described in the Text S1. It is important 
to remark, however, that the progression from one class to the next one must not be understood as a 
“shift”, but rather as a better approximation (see Table 1 and/or Text S1, Equations 3 and 4) which 
becomes necessary as the tumor ages. 
 
 
 
Figure 2. The three phases of growth of MTS's. 
Temporal evolution of a MTS made of EMT6/Ro mouse mammary carcinoma cells grown in a confined culture medium. 
The experimental data (triangles) are taken from Ref. [26]. The “squares” and “circles” correspond to the total numbers 
of MTS cells and necrotic cells, respectively. They have been obtained from a mesoscopic simulation [20], [27], based 
on the model of P. P. Delsanto and collaborators [28]–[30]. In the figure three regions may be well identified. In the first 
one, corresponding in the formalism of the Text S1 to the PUN class U0, there is an almost perfect exponential growth 
without necrotic core formation. In the second phase, which requires a better approximation as provided by U1, a bending 
of the growth curve towards some asymptotic level of saturation can be clearly observed: may be related to the decreasing 
availability of nutrients for the growing MTS. In the third phase (U2), a better agreement with the experimental data may 
be obtained by considering the next level of approximation (PUN class U2). 
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Figure 3. Schematic representation of the three UN phases. 
In U0 the MTS has no core, but starts developing it in U1. The third box represents three possible evolutionary scenarios 
for U2 of a tumor in vivo (not of a MTS), i.e. tumor invasion [18], [31], angiogenesis [32] and metastatic diffusion [19]. 
 
 
 
 
  
Table 1. Explicit expression of the generating functions b(a), growth rate a(t), and z(t) = ln[y(t)] for the three 
classes U0, U1, and U2. 
 
 
Let us now assume that we always transplant “young” tumors, i.e. that a new seed of approximately 
the same mass is taken each time after a short time (e.g. ten days) after each transplant. Then we 
can assume to have always an exponential growth law with approximately the same rate C. It follows 
that, at the time  after transplants, i.e.  the tumor mass will be given, at least as a first 
approximation, by 
  
(1) 
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In order to have m(t) = m0 at the outset of each new transplant, we must have 
for every value of , hence  and ( ). It follows: 
 
(2) 
where  and . Equation (2) shows that the exponential trend is corrected by a 
term ( ), which accounts for the real age of the tumor and increases at each transplant, thus 
accelerating the growth. I.e., at each transplant the curves become steeper and steeper. Other 
explanations for the growth acceleration are also possible, e.g. a lack of accumulated toxic wastes in 
the new host and/or the emergence of a more aggressive subpopulations. 
It is interesting to note that the Equation (2) can be viewed as a Taylor expansion of the Gompertzian 
law at the first order on . 
If, after a limited number  of transplants, we wish to follow the tumor growth for a large time  
then it is no longer possible to assume that we have a purely exponential growth, since we eventually 
enter into phases one and two. Thus, for a best fitting of the experimental curves the formalism of 
class U2 must be adopted (Text S1, Equation 5). Also, in order to keep into account the growth 
acceleration after passages, as discussed before, it is convenient to renormalize the physical time , 
using instead 
 
(3) 
where the acceleration parameter ρ increases with the number of transplants . 
 
Results 
As a first instance of application of our approach, we consider the classical work of G. G. Steel [9], 
who performed up to ten “passages” of cells from the tumoral line rat fibroadenoma, (see Figure 4). 
As discussed in the previous Section, the growth curves became increasingly steeper at each 
successive passage, as it can be inferred also from an analysis of the fitting parameters (see Table 2). 
In fact, the y-derivative in t = 0 is steeper at each successive passage. However, contrary to what one 
could expect, the asymptotic value of the tumor mass, given by (see Text S1, Equation 5) 
 
(4) 
decreases with the number of transplants, since β<0. 
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Figure 4. MPE results from G. G. Steel. 
Up to 10 transplants of cells from the tumoral line rat fibroadenoma have been performed, but the curves corresponding 
to only four of them have been reported [9]: see (A). As discussed in Methods, the averaged growth curves become 
increasingly steeper with successive passages, due to the aging of the newly transplanted tumor cells. By rescaling the 
time (see Equation 3) with a suitable choice of the parameter ρ, we obtain a plot (B), in which all the curves are collapsed 
into a single one, belonging to the PUN class U2. The fitting parameters are reported in Table 2. 
 
 
 
 
Table 2. U2 fitting parameters for the data from [9]. 
 
A very interesting follow-up to Steel's data, which to our knowledge has not been recognized by other 
researchers, is the following. If we “renormalize” his data by means of a simple rescaling of the time 
(see Equation (3)), after a suitable choice of the parameter ρ we obtain a plot (Figure 4B), in which 
all the curves corresponding to the various passages, are collapsed into a single one, belonging to a 
very good approximation (R2 = 0.98016) to the PUN class U2 (Text S1, Equation 5). This result, 
besides its intrinsic interest (since it means that a tumor after transplant keeps growing with the same 
law as before, as discussed previously), is also of great relevance for our analysis, since it allows the 
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accumulation of a large number of independent datapoints. It may also be interesting to observe that 
the parameter ρ (which can be obtained from Equation 3 and Figure 5A) seems to vary linearly with 
the number of passages, as shown in Figure 5B. However, since only the data for four transplants 
were reported, no firm conclusion can be reached on this point. 
 
 
 
Figure 5. Variation of the “acceleration” parameter ρ with the passage number. 
In (A) the experimental data from [9] have been plotted in a semi-logarithmic plane and fitted, in a first approximation, 
with a linear function. For each passage n it is then possible to extract from the angular coefficients the values of the 
acceleration parameter ρ, obtained experimentally (A) and theoretically (by collapsing together the four curves of Figure 
4A as done in Figure 4B). 
 
In order to confirm the validity of our approach, we have extended it to another set of data, from the 
paper of McCredie et al. [10]. In their paper the rate of growth of the C3H spontaneous mammary 
carcinoma in the mouse is compared with that of its first and 900th generation syngeneic transplants 
(see Figure 6). The results of our analysis are presented in Figure 6 and the fitting parameters reported 
in Table 3. 
8 
 
 
Figure 6. MPE results from McCredie et al. [10]. 
As many as 900 transplants of cells from the tumoral line C3H rat mammary carcinoma have been performed, but the 
curves corresponding to only the original one, the first and the last (900th) transplant have been reported: (A–C), 
respectively. For all of them the fits of the data corresponding to the classes U0, U1, and U2 have been included. There 
is an obvious improvement when one goes from U0 to U1 and a much smaller one from U1 to U2. The latter, in fact, 
yelds an almost perfect agreement with the experimental data. As in the case of Steel's data, in (D) the growth curves are 
normalized and displayed as a single group of data vs. the rescaled time τ. Here, as in Figure 4B, a U2 curve gives an 
excellent fit to the regrouped data. It is indeed remarkable that after as many as 900 transplants the tumor still grows with 
the same law (a part from the time “rescaling”). The fitting parameters are reported in Table 3. 
 
 
 
Table 3. U2 fitting parameters for the data from [10]. 
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The MPE growth acceleration has also been observed by other researchers [21], [22] who, 
unfortunately, did not report the detailed growth data necessary for a computational analysis. It is 
important to remark that the timing of the re-implantation as well as the dimension reached by the 
tumor before transplantation may be very different in different experiments. Allowing the tumor to 
become large before transplantation invalidates the assumption of ‘unrestricted growth’ so that the 
tumor-host interaction becomes more and more important. This makes multipassage models 
interesting for understanding other biological mechanisms involved. For instance, after implantation, 
subpopulations of other apparently uniform cell populations may develop, with different properties 
of proliferation, migration, and metastasis [23]. 
In other development, Shen et al. [24] studied the cellular adjustment of gastric cancer for hepatic 
metastasis in successive orthotopic implantation models. The authors compared the parental cell line 
(YCC-16) with those obtained by inoculation into nude mice after 1, 2 and 3 passages (S1L1, S2L2 
and S3L3 respectively). They found that, although slower than the parental line, the doubling time 
decreased from S1L1 to S3L3 while clonogenity increased. A progressive increase in the expression 
of matrix-metalloproteasis MMP-2 ( i.e. the ability of invasion) was observed. Also Beniers et al. 
[21], investigating five lines of renal tumors transplanted in mice after reaching al least 1 cm in 
diameter, were able to show differences in ‘tumor aggressivity’, i.e. clonogenity, metastasis capacity, 
etc., between the 5th and the 15th passage. 
 
Discussion 
The accelerated growth of transplanted tumors at each successive passage challenges our 
understanding of tumor development. In fact, it is well known that multipassaging in in vitro setups 
does not show any remarkable variation in growth rate [23]; when the same cell line is implanted in 
animal models, on the contrary, the growth accelerates significantly at each new passage. 
In this contribution we have analyzed two instances of multipassage experiments in mice: the classical 
studies of Steel [9] and of McCredie et al. [10]. As a tool for the analysis of their datasets we have 
applied the Phenomenological Universalities approach [1], which has been fruitfully utilized for 
application in different fields (among them: auxology (human growth) [3], elastodynamics [4] and 
fracture mechanics [25]). Perhaps the most important PUN class studied to date is the class UN, which 
at the first level ( ), corresponds to unrestricted exponential growth. At the level , it yields 
the Gompertz law, which has been used, up to few years ago, to fit almost all growth phenomena. 
Finally, at the level  (i.e. U2), it successfully predicts the fractal properties of the 
solution of the growth equation at larger times. By applying the PUN approach to the data of Steel 
[9] and McCredie et al. [10], we have found that the class U2 describes extremely well both their 
datasets, although with accelerated time scales. 
We have also found an explanation for this acceleration. In fact if, as in the two cases been analyzed, 
the transplants are always performed after a short time , with only relatively few cells reimplanted 
into a new healthy and well oxigenated host, their growth occurs in virtually unrestricted conditions. 
From a mathematical point of view we keep having always approximately the same exponential 
growth  during each successive transplantation. But the cumulative effects of a certain 
number of transplants yields a term , which may be responsible for the accelerated growth 
(see Equation 1). In other words, the tumor cells are as old as the seed taken at the very beginning 
and they grow correspondingly faster. This result may have important consequences in clinical 
practice. In fact, if one or more parameters of the system do not change upon transplantation, they 
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could be considered as a sort of ‘fingerprints’ of a specific tumor. Then, a very important corollary to 
our work could perhaps be the study of metastatic diffusion, since the parameters of secondary 
neoplasies would be as well related to the ones of the primary tumor. Their growth rate would be 
speeded (as discussed for the MPE's), albeit possibly also slowed down by host and other restrictions. 
Unfortunately, to our knowledge, no recent data on MPE's are available. Further experimental 
evidence is, of course, needed, in order to confirm the validity of our conjecture and, in particular, to 
ascertain the dependence of the acceleration parameter ρ on the passage number, which in Figure 5b 
has been assumed to be linear on the basis of a limited number of data [9]. 
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Supporting Information 
TEXT S1: The Phenomenological Universalities Approach – The formalism 
In addition to their epistemological interst, PUN’s can be applied as a tool for the solution of a variety 
of problems [1-4]. We restrict ourselves here to discuss their application to the following one: given 
the string of data ( )i iy y t , ( 1,..., )i I , representing e.g. the temporal evolution of the mass or 
volume of the tumor, then 
1) find a best fitting function ( )y t , based not on an “ad hoc” numerical procedure, but on a 
general formalism independent of the field of application. 
2) from the fitting function obtain a model for the proposed phenomenology. 
In typical nonlinear growth problems, one may assume that 
( , ) ( )y a y t y t ,      (1) 
where dyy
dt
  and a  represents the growth rate. By defining ln( )z y , Eq. (1) becomes simply  
z a        2) 
In general ( , )a a z t , but in the following we restrict ourselves to the case ( )a a z . The cases 
( )a a t and a given by a sum of contributions from two terms, ( )a z and ( )a t , each depending on 
only one of the two variables, are discussed in [3] . We then assume that 
( ) da dab a b a z a
dz dz
     ,    3) 
with 
2 ...da a a
dz
           (4) 
If we truncate this expansion at the N-th term and obtain hereby a good fitting of the dataset ( )y t , 
then we call UN the corresponding PUN class. By solving the two differential equation ( )da b a
dt
 , 
and Eq.(2), one obtains the results for ( )a t  and ( )z t , which are summarized in Table 1 for N = 0,1,2.  
From Tab. 1 and exp( )y z  we obtain the U2 growth law  
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  11 1 ty e            (5) 
where 0a   . 
 
It can be easily proven that y satisfies the Ordinary Differential Equation  
1 2
p dyc y c y
dt
        (6) 
where 2 1 21 , , (1 ).p c c c
       Equation (6) can be interpreted as an energy conservation 
law in which the input energy 1
pc y is partly used for growth (up to saturation) and partly for metabolic 
consumption. Since p is in general non integer, Equation (6) implies a fractal nature of the energy 
source. Other interpretations of Equation (6) are, of course, possible, depending on the field of 
application. 
